论文部分内容阅读
目的:对高血压治疗中应用不同降压药物的临床疗效进行分析。方法:选取高血压患者75例,将患者随机分为甲、乙、丙三组各25例,分别给予倍博特、代文、络活喜等降压药物治疗,对三组患者降压效果及不良反应发生情况进行分析。结果:治疗4周及8周后三组患者SBP与DBP均有显著降低,且甲组下降程度显著优于乙组和丙组(P<0.05)。三组不良反应发生率间差异不显著(P>0.05)。结论:在原发性高血压治疗中,倍博特具有显著降压效果,不良反应发生率低,值得在临床中推广。
Objective: To analyze the clinical efficacy of different antihypertensive drugs in the treatment of hypertension. Methods: Seventy-five patients with hypertension were selected and randomly divided into two groups: 25 cases in each of group A, B and C, which were treated with antihypertensive drugs such as Betoxon, Daiwen and Luohuoxi respectively. The antihypertensive effects And adverse reactions were analyzed. Results: SBP and DBP were significantly decreased in the three groups after 4 weeks and 8 weeks of treatment, and the decline in group A was significantly better than those in groups B and C (P <0.05). There was no significant difference between the three groups in the incidence of adverse reactions (P> 0.05). Conclusion: Betoet has a significant antihypertensive effect in the treatment of essential hypertension, and the incidence of adverse reactions is low, which is worth to be popularized clinically.